跳至主要内容
临床试验/JPRN-UMIN000042753
JPRN-UMIN000042753已完成未知

Effect of Daily Ingestion of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study - Beneficial Effects of Partially Hydrolyzed Guar Gum (PHGG) on Immune Function

Hokkaido Information University0 个研究点目标入组 100 人开始时间: 2020年12月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who are under treatment or medication for autoimmune diseases, chronic inflammatory diseases or allergies. 2. Subjects who plan to receive influenza vaccination from the screening test date to the end of intake. 3. Subjects with serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal or affected with infectious diseases which is required to report to the authorities. 4. Subjects who have a major surgical history such as gastrectomy, gastrorrhaphy, enterectomy or other serious gastrointestinal surgeries. 5. Subjects with unusually high and/or low blood pressure, abnormal physical data and/or abnormal hematological data. 6. Subjects with severe anemia. 7. Pre- or post-menopausal women complaining of obvious physical changes. 8. Subjects who are at risk of having allergic reactions to drugs, foods (especially soybeans or peanuts) and/or birch pollen. 9. Subjects who regularly take medicines (Antibiotics, immunosuppressants, anti-inflammatory drugs, antirheumatic drugs, antihistamines, antiallergic drugs, lactic acid bacteria preparations), functional food and/or supplements (mushrooms, seaweed, nucleic acids, yeast, lactobacillus, etc.) which would affect the immune function. 10. Heavy smokers, alcohol addicts or subjects with irregular lifestyle. 11. Subjects who donated either 400 ml whole blood within 16 weeks (women), 12 weeks (men), 200 ml whole blood within 4 weeks, or blood components within 2 weeks, prior to the current study. 12. Pregnant or lactating women or women who expect to be pregnant during this study. 13. Subjects who currently participate in other clinical trials, or participated within the last 4 weeks prior to the current study. 14. Subjects determined to be ineligible by the principal investigator.

研究者

相似试验